ECTRIMS 2023Multiple Sclerosis News Today is providing in-depth coverage of the ninth joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), taking place in Milan, Italy...
Kesimpta (ofatumumab) is more effective than Aubagio (teriflunomide) among people with multiple sclerosis (MS) from ethnically diverse groups, including Black and African American, Hispanic and Latino, and Asian individuals, according to an analysis of pooled clinical trial data. “Determining whether...
Krupp LB, Hertz DP. Pediatric multiple sclerosis: Conference Report Overview. Neurology 2007;68(Suppl 2):S81-S82.Krupp LB, Hertz DP. Pediatric multiple sclerosis: Conference Report overview. Neurology. 2007;68(16 suppl 2):S1-S2. http://dx.doi.org/ 10.1212/01.wnl.0000259418.59521.0c....
Stem cell transplantation (SCT) has emerged as another treatment option for multiple sclerosis in addition to different autoimmune neurological diseases such as myasthenia gravis, Neuromyelitis optica, and systemic inflammatory diseases including rheumatoid arthritis and systemic lupus erythematosus10,11. SCT ...
Dates: Wednesday, May 28, 2025 - Saturday, May 31, 2025 Venue: Phoenix Convention Center,Phoenix AZ,United States CMSC Annual meeting is the leading multi-disciplinary event in North America for healthcare professionals on the diagnosis, treatment, and management of multiple sclerosis.'Posters and...
We present a study of multiple sclerosis segmentation algorithms conducted at the international MICCAI 2016 challenge. This challenge was operated using a new open-science computing infrastructure. This allowed for the automatic and independent evaluatio
Independently supported satellite programs will also offer additional accredited learning opportunities in multiple sclerosis. For more information on the CMSC & ACTRIMS Meeting and to register, visit: www.cmsc-actrims.org. ### About CMSC The Consortium of Multiple Sclerosis Centers (CMSC) ...
Not too long ago, multiple sclerosis (MS) was notnonly considered untreatable, but there was widespreadnskepticism that successful treatments werenforthcom... RA Rudick - 《Therapy》 被引量: 0发表: 2008年 Interferon β for secondary progressive multiple sclerosis the Cochrane Multiple Sclerosis Grou...
Xydas, E.G., Louca, L.S.: Design and Development of a Haptic Peg-Board Exercise for the Rehabilitation of People with Multiple Sclerosis. In: IEEE ... EG Xydas,LS Louca - IEEE International Conference on Rehabilitation Robotics 被引量: 15发表: 2008年 Multiple Sclerosis and Exercise MULTPLE...
Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS). Although disease-modifying therapies have been efficacious for reducing relapse rates in MS, such treatments are ineffective for treating cognitive dysfunction. Al